Loading…

Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis

Magnetic resonance cholangiopancreatography (MRCP) is used for the diagnosis and follow-up of individuals with primary sclerosing cholangitis (PSC). The aim of our study was to develop an MRCP-score based on cholangiographic findings previously associated with outcomes and assess its reproducibility...

Full description

Saved in:
Bibliographic Details
Published in:JHEP reports 2022-12, Vol.4 (12), p.100595-100595, Article 100595
Main Authors: Grigoriadis, Aristeidis, Imeen Ringe, Kristina, Bengtsson, Johan, Baubeta, Erik, Forsman, Cecilia, Korsavidou-Hult, Nafsika, Rorsman, Fredrik, Nilsson, Emma, Kartalis, Nikolaos, Bergquist, Annika
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c627t-dccebfdae4fd1e4e1e84b86716a151373baf27de05b70515fa7e2347f2a91de93
cites cdi_FETCH-LOGICAL-c627t-dccebfdae4fd1e4e1e84b86716a151373baf27de05b70515fa7e2347f2a91de93
container_end_page 100595
container_issue 12
container_start_page 100595
container_title JHEP reports
container_volume 4
creator Grigoriadis, Aristeidis
Imeen Ringe, Kristina
Bengtsson, Johan
Baubeta, Erik
Forsman, Cecilia
Korsavidou-Hult, Nafsika
Rorsman, Fredrik
Nilsson, Emma
Kartalis, Nikolaos
Bergquist, Annika
description Magnetic resonance cholangiopancreatography (MRCP) is used for the diagnosis and follow-up of individuals with primary sclerosing cholangitis (PSC). The aim of our study was to develop an MRCP-score based on cholangiographic findings previously associated with outcomes and assess its reproducibility and prognostic value in PSC. The score (DiStrict score) was developed based on the extent and severity of cholangiographic changes to intrahepatic and extrahepatic bile ducts (range 0–8) on 3D-MRCP. In this retrospective, multicentre study, three pairs of radiologists with different levels of expertise from three tertiary centres applied the score independently. MRCP examinations of 220 consecutive individuals with PSC from a prospectively collected PSC-cohort, with median follow-up of 7.4 years, were reviewed. Inter-reader and intrareader agreements were assessed via intraclass correlation coefficient (ICC). After consensus, the prognostic value of the score was assessed using Cox-regression and outcome-free survival rates were assessed via Kaplan-Meier estimates. Harrell's C-statistic was calculated. Forty patients developed outcomes (liver transplantation or liver-related death). Inter-reader agreement between experienced radiologists was good (ICC 0.82; 95% CI 0.74–0.87, and ICC 0.81; 95% CI 0.70–0.87, respectively) and better than the agreement for the pair of experienced/less-experienced radiologists (ICC 0.48; 95% CI 0.05–0.72). Agreement between radiologists from the three centres was good (ICC 0.76; 95% CI 0.57–0.89). Intrareader agreement was good to excellent (ICC 0.85–0.93). Harrell's C was 0.78. Patients with a DiStrict score of 5–8 had 8.2-fold higher risk (hazard ratio 8.2; 95% CI 2.97–22.65) of developing outcomes, and significantly worse survival (p
doi_str_mv 10.1016/j.jhepr.2022.100595
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6f75dffd24fd437bb81b162a3c2730b2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2589555922001677</els_id><doaj_id>oai_doaj_org_article_6f75dffd24fd437bb81b162a3c2730b2</doaj_id><sourcerecordid>2742656391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c627t-dccebfdae4fd1e4e1e84b86716a151373baf27de05b70515fa7e2347f2a91de93</originalsourceid><addsrcrecordid>eNp9Uk2P0zAQjRBIrJb9BVx8XCRSbCeOkwNIq5aPlRaB-Lpajj1OXdK4aydd8e-ZNhWiBzhYsSbvvXmeN1n2nNEFo6x6tVls1rCLC045xwoVjXiUXXBRN7kQonn81_1pdpXShlLKZVMi9yLbrWAPfdhtYRhJcESTXQzdENLoDfn4Zfk5TyZEINcr_3WM3owviAuR-MH6vbeT7hN58OOa9Dp2kNvJjCjgtzr-Isn0EEPyQ0fMOvR66Pzo07PsiUMWXJ2-l9n3d2-_LT_kd5_e3y5v7nJTcTnm1hhondVQOsugBAZ12daVZJVmghWyaLXj0gIVraSCCacl8KKUjuuGWWiKy-x21rVBb9TJkwraq2MhxE7piI_sQVVOCuuc5dirLGTb1qxlFdeF4bKgLUetZtZKD7Cb2jM1HJdVp_pPfzgqgUKPZVlLUSH35T-5K__j5uhkmlTZFExShL-Z4YjdgjUYS9T9ecezP4Nfqy7sVSMx1kKgwPVJIIb7CdKotj4Z6HH-EKakuCx5hb4ahtBihhqMKUVwf9owqg6rpTbquFrqsFpqXi1kvZ5ZgOntPUSVjIfBgPURzIjj9f_l_wbMk9ya</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2742656391</pqid></control><display><type>article</type><title>Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis</title><source>PubMed Central(OpenAccess)</source><source>Elsevier ScienceDirect Journals</source><creator>Grigoriadis, Aristeidis ; Imeen Ringe, Kristina ; Bengtsson, Johan ; Baubeta, Erik ; Forsman, Cecilia ; Korsavidou-Hult, Nafsika ; Rorsman, Fredrik ; Nilsson, Emma ; Kartalis, Nikolaos ; Bergquist, Annika</creator><creatorcontrib>Grigoriadis, Aristeidis ; Imeen Ringe, Kristina ; Bengtsson, Johan ; Baubeta, Erik ; Forsman, Cecilia ; Korsavidou-Hult, Nafsika ; Rorsman, Fredrik ; Nilsson, Emma ; Kartalis, Nikolaos ; Bergquist, Annika</creatorcontrib><description>Magnetic resonance cholangiopancreatography (MRCP) is used for the diagnosis and follow-up of individuals with primary sclerosing cholangitis (PSC). The aim of our study was to develop an MRCP-score based on cholangiographic findings previously associated with outcomes and assess its reproducibility and prognostic value in PSC. The score (DiStrict score) was developed based on the extent and severity of cholangiographic changes to intrahepatic and extrahepatic bile ducts (range 0–8) on 3D-MRCP. In this retrospective, multicentre study, three pairs of radiologists with different levels of expertise from three tertiary centres applied the score independently. MRCP examinations of 220 consecutive individuals with PSC from a prospectively collected PSC-cohort, with median follow-up of 7.4 years, were reviewed. Inter-reader and intrareader agreements were assessed via intraclass correlation coefficient (ICC). After consensus, the prognostic value of the score was assessed using Cox-regression and outcome-free survival rates were assessed via Kaplan-Meier estimates. Harrell's C-statistic was calculated. Forty patients developed outcomes (liver transplantation or liver-related death). Inter-reader agreement between experienced radiologists was good (ICC 0.82; 95% CI 0.74–0.87, and ICC 0.81; 95% CI 0.70–0.87, respectively) and better than the agreement for the pair of experienced/less-experienced radiologists (ICC 0.48; 95% CI 0.05–0.72). Agreement between radiologists from the three centres was good (ICC 0.76; 95% CI 0.57–0.89). Intrareader agreement was good to excellent (ICC 0.85–0.93). Harrell's C was 0.78. Patients with a DiStrict score of 5–8 had 8.2-fold higher risk (hazard ratio 8.2; 95% CI 2.97–22.65) of developing outcomes, and significantly worse survival (p &lt;0.001), compared to those with a DiStrict score of 1–4. The novel DiStrict score is reproducible and strongly associated with outcomes, indicating its prognostic value for individuals with PSC in clinical practice. The diagnosis of primary sclerosing cholangitis (PSC) is based on magnetic resonance cholangiopancreatography (MRCP). However, the role of MRCP in the prognostication of PSC is still unclear. We developed a novel, simple, and reproducible risk-score, based on MRCP findings, that showed a strong association with prognosis in individuals with PSC (DiStrict score). This score can be easily used in clinical practice and thus has the potential to be useful in clinical trials and in patient counselling and management. [Display omitted] •We developed a novel MRCP-score (DiStrict score) for large-duct PSC based on MRCP-findings.•The DiStrict score is based on presence and extent of biliary strictures and dilatations.•The DiStrict score can predict liver transplantation and liver-related death.•Patients with high DiStrict scores have worse survival.•The District score is easy to apply and reproducible.</description><identifier>ISSN: 2589-5559</identifier><identifier>EISSN: 2589-5559</identifier><identifier>DOI: 10.1016/j.jhepr.2022.100595</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Bile ducts ; Cholangiopancreatography ; Cholangitis sclerosing ; Magnetic resonance ; Medicin och hälsovetenskap ; Prognosis</subject><ispartof>JHEP reports, 2022-12, Vol.4 (12), p.100595-100595, Article 100595</ispartof><rights>2022 The Author(s)</rights><rights>2022 The Author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c627t-dccebfdae4fd1e4e1e84b86716a151373baf27de05b70515fa7e2347f2a91de93</citedby><cites>FETCH-LOGICAL-c627t-dccebfdae4fd1e4e1e84b86716a151373baf27de05b70515fa7e2347f2a91de93</cites><orcidid>0000-0002-5562-449X ; 0000-0002-3858-6241 ; 0000-0002-9016-5858 ; 0000-0003-4023-9617 ; 0000-0001-9177-7322 ; 0000-0001-8003-1787</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700035/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2589555922001677$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-493170$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:151448756$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Grigoriadis, Aristeidis</creatorcontrib><creatorcontrib>Imeen Ringe, Kristina</creatorcontrib><creatorcontrib>Bengtsson, Johan</creatorcontrib><creatorcontrib>Baubeta, Erik</creatorcontrib><creatorcontrib>Forsman, Cecilia</creatorcontrib><creatorcontrib>Korsavidou-Hult, Nafsika</creatorcontrib><creatorcontrib>Rorsman, Fredrik</creatorcontrib><creatorcontrib>Nilsson, Emma</creatorcontrib><creatorcontrib>Kartalis, Nikolaos</creatorcontrib><creatorcontrib>Bergquist, Annika</creatorcontrib><title>Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis</title><title>JHEP reports</title><description>Magnetic resonance cholangiopancreatography (MRCP) is used for the diagnosis and follow-up of individuals with primary sclerosing cholangitis (PSC). The aim of our study was to develop an MRCP-score based on cholangiographic findings previously associated with outcomes and assess its reproducibility and prognostic value in PSC. The score (DiStrict score) was developed based on the extent and severity of cholangiographic changes to intrahepatic and extrahepatic bile ducts (range 0–8) on 3D-MRCP. In this retrospective, multicentre study, three pairs of radiologists with different levels of expertise from three tertiary centres applied the score independently. MRCP examinations of 220 consecutive individuals with PSC from a prospectively collected PSC-cohort, with median follow-up of 7.4 years, were reviewed. Inter-reader and intrareader agreements were assessed via intraclass correlation coefficient (ICC). After consensus, the prognostic value of the score was assessed using Cox-regression and outcome-free survival rates were assessed via Kaplan-Meier estimates. Harrell's C-statistic was calculated. Forty patients developed outcomes (liver transplantation or liver-related death). Inter-reader agreement between experienced radiologists was good (ICC 0.82; 95% CI 0.74–0.87, and ICC 0.81; 95% CI 0.70–0.87, respectively) and better than the agreement for the pair of experienced/less-experienced radiologists (ICC 0.48; 95% CI 0.05–0.72). Agreement between radiologists from the three centres was good (ICC 0.76; 95% CI 0.57–0.89). Intrareader agreement was good to excellent (ICC 0.85–0.93). Harrell's C was 0.78. Patients with a DiStrict score of 5–8 had 8.2-fold higher risk (hazard ratio 8.2; 95% CI 2.97–22.65) of developing outcomes, and significantly worse survival (p &lt;0.001), compared to those with a DiStrict score of 1–4. The novel DiStrict score is reproducible and strongly associated with outcomes, indicating its prognostic value for individuals with PSC in clinical practice. The diagnosis of primary sclerosing cholangitis (PSC) is based on magnetic resonance cholangiopancreatography (MRCP). However, the role of MRCP in the prognostication of PSC is still unclear. We developed a novel, simple, and reproducible risk-score, based on MRCP findings, that showed a strong association with prognosis in individuals with PSC (DiStrict score). This score can be easily used in clinical practice and thus has the potential to be useful in clinical trials and in patient counselling and management. [Display omitted] •We developed a novel MRCP-score (DiStrict score) for large-duct PSC based on MRCP-findings.•The DiStrict score is based on presence and extent of biliary strictures and dilatations.•The DiStrict score can predict liver transplantation and liver-related death.•Patients with high DiStrict scores have worse survival.•The District score is easy to apply and reproducible.</description><subject>Bile ducts</subject><subject>Cholangiopancreatography</subject><subject>Cholangitis sclerosing</subject><subject>Magnetic resonance</subject><subject>Medicin och hälsovetenskap</subject><subject>Prognosis</subject><issn>2589-5559</issn><issn>2589-5559</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9Uk2P0zAQjRBIrJb9BVx8XCRSbCeOkwNIq5aPlRaB-Lpajj1OXdK4aydd8e-ZNhWiBzhYsSbvvXmeN1n2nNEFo6x6tVls1rCLC045xwoVjXiUXXBRN7kQonn81_1pdpXShlLKZVMi9yLbrWAPfdhtYRhJcESTXQzdENLoDfn4Zfk5TyZEINcr_3WM3owviAuR-MH6vbeT7hN58OOa9Dp2kNvJjCjgtzr-Isn0EEPyQ0fMOvR66Pzo07PsiUMWXJ2-l9n3d2-_LT_kd5_e3y5v7nJTcTnm1hhondVQOsugBAZ12daVZJVmghWyaLXj0gIVraSCCacl8KKUjuuGWWiKy-x21rVBb9TJkwraq2MhxE7piI_sQVVOCuuc5dirLGTb1qxlFdeF4bKgLUetZtZKD7Cb2jM1HJdVp_pPfzgqgUKPZVlLUSH35T-5K__j5uhkmlTZFExShL-Z4YjdgjUYS9T9ecezP4Nfqy7sVSMx1kKgwPVJIIb7CdKotj4Z6HH-EKakuCx5hb4ahtBihhqMKUVwf9owqg6rpTbquFrqsFpqXi1kvZ5ZgOntPUSVjIfBgPURzIjj9f_l_wbMk9ya</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>Grigoriadis, Aristeidis</creator><creator>Imeen Ringe, Kristina</creator><creator>Bengtsson, Johan</creator><creator>Baubeta, Erik</creator><creator>Forsman, Cecilia</creator><creator>Korsavidou-Hult, Nafsika</creator><creator>Rorsman, Fredrik</creator><creator>Nilsson, Emma</creator><creator>Kartalis, Nikolaos</creator><creator>Bergquist, Annika</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACNBI</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DF2</scope><scope>ZZAVC</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5562-449X</orcidid><orcidid>https://orcid.org/0000-0002-3858-6241</orcidid><orcidid>https://orcid.org/0000-0002-9016-5858</orcidid><orcidid>https://orcid.org/0000-0003-4023-9617</orcidid><orcidid>https://orcid.org/0000-0001-9177-7322</orcidid><orcidid>https://orcid.org/0000-0001-8003-1787</orcidid></search><sort><creationdate>20221201</creationdate><title>Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis</title><author>Grigoriadis, Aristeidis ; Imeen Ringe, Kristina ; Bengtsson, Johan ; Baubeta, Erik ; Forsman, Cecilia ; Korsavidou-Hult, Nafsika ; Rorsman, Fredrik ; Nilsson, Emma ; Kartalis, Nikolaos ; Bergquist, Annika</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c627t-dccebfdae4fd1e4e1e84b86716a151373baf27de05b70515fa7e2347f2a91de93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bile ducts</topic><topic>Cholangiopancreatography</topic><topic>Cholangitis sclerosing</topic><topic>Magnetic resonance</topic><topic>Medicin och hälsovetenskap</topic><topic>Prognosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grigoriadis, Aristeidis</creatorcontrib><creatorcontrib>Imeen Ringe, Kristina</creatorcontrib><creatorcontrib>Bengtsson, Johan</creatorcontrib><creatorcontrib>Baubeta, Erik</creatorcontrib><creatorcontrib>Forsman, Cecilia</creatorcontrib><creatorcontrib>Korsavidou-Hult, Nafsika</creatorcontrib><creatorcontrib>Rorsman, Fredrik</creatorcontrib><creatorcontrib>Nilsson, Emma</creatorcontrib><creatorcontrib>Kartalis, Nikolaos</creatorcontrib><creatorcontrib>Bergquist, Annika</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SWEPUB Uppsala universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Uppsala universitet</collection><collection>SwePub Articles full text</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>JHEP reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grigoriadis, Aristeidis</au><au>Imeen Ringe, Kristina</au><au>Bengtsson, Johan</au><au>Baubeta, Erik</au><au>Forsman, Cecilia</au><au>Korsavidou-Hult, Nafsika</au><au>Rorsman, Fredrik</au><au>Nilsson, Emma</au><au>Kartalis, Nikolaos</au><au>Bergquist, Annika</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis</atitle><jtitle>JHEP reports</jtitle><date>2022-12-01</date><risdate>2022</risdate><volume>4</volume><issue>12</issue><spage>100595</spage><epage>100595</epage><pages>100595-100595</pages><artnum>100595</artnum><issn>2589-5559</issn><eissn>2589-5559</eissn><abstract>Magnetic resonance cholangiopancreatography (MRCP) is used for the diagnosis and follow-up of individuals with primary sclerosing cholangitis (PSC). The aim of our study was to develop an MRCP-score based on cholangiographic findings previously associated with outcomes and assess its reproducibility and prognostic value in PSC. The score (DiStrict score) was developed based on the extent and severity of cholangiographic changes to intrahepatic and extrahepatic bile ducts (range 0–8) on 3D-MRCP. In this retrospective, multicentre study, three pairs of radiologists with different levels of expertise from three tertiary centres applied the score independently. MRCP examinations of 220 consecutive individuals with PSC from a prospectively collected PSC-cohort, with median follow-up of 7.4 years, were reviewed. Inter-reader and intrareader agreements were assessed via intraclass correlation coefficient (ICC). After consensus, the prognostic value of the score was assessed using Cox-regression and outcome-free survival rates were assessed via Kaplan-Meier estimates. Harrell's C-statistic was calculated. Forty patients developed outcomes (liver transplantation or liver-related death). Inter-reader agreement between experienced radiologists was good (ICC 0.82; 95% CI 0.74–0.87, and ICC 0.81; 95% CI 0.70–0.87, respectively) and better than the agreement for the pair of experienced/less-experienced radiologists (ICC 0.48; 95% CI 0.05–0.72). Agreement between radiologists from the three centres was good (ICC 0.76; 95% CI 0.57–0.89). Intrareader agreement was good to excellent (ICC 0.85–0.93). Harrell's C was 0.78. Patients with a DiStrict score of 5–8 had 8.2-fold higher risk (hazard ratio 8.2; 95% CI 2.97–22.65) of developing outcomes, and significantly worse survival (p &lt;0.001), compared to those with a DiStrict score of 1–4. The novel DiStrict score is reproducible and strongly associated with outcomes, indicating its prognostic value for individuals with PSC in clinical practice. The diagnosis of primary sclerosing cholangitis (PSC) is based on magnetic resonance cholangiopancreatography (MRCP). However, the role of MRCP in the prognostication of PSC is still unclear. We developed a novel, simple, and reproducible risk-score, based on MRCP findings, that showed a strong association with prognosis in individuals with PSC (DiStrict score). This score can be easily used in clinical practice and thus has the potential to be useful in clinical trials and in patient counselling and management. [Display omitted] •We developed a novel MRCP-score (DiStrict score) for large-duct PSC based on MRCP-findings.•The DiStrict score is based on presence and extent of biliary strictures and dilatations.•The DiStrict score can predict liver transplantation and liver-related death.•Patients with high DiStrict scores have worse survival.•The District score is easy to apply and reproducible.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.jhepr.2022.100595</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-5562-449X</orcidid><orcidid>https://orcid.org/0000-0002-3858-6241</orcidid><orcidid>https://orcid.org/0000-0002-9016-5858</orcidid><orcidid>https://orcid.org/0000-0003-4023-9617</orcidid><orcidid>https://orcid.org/0000-0001-9177-7322</orcidid><orcidid>https://orcid.org/0000-0001-8003-1787</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2589-5559
ispartof JHEP reports, 2022-12, Vol.4 (12), p.100595-100595, Article 100595
issn 2589-5559
2589-5559
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_6f75dffd24fd437bb81b162a3c2730b2
source PubMed Central(OpenAccess); Elsevier ScienceDirect Journals
subjects Bile ducts
Cholangiopancreatography
Cholangitis sclerosing
Magnetic resonance
Medicin och hälsovetenskap
Prognosis
title Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A16%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20a%20prognostic%20MRCP-score%20(DiStrict)%20for%20individuals%20with%20large-duct%20primary%20sclerosing%20cholangitis&rft.jtitle=JHEP%20reports&rft.au=Grigoriadis,%20Aristeidis&rft.date=2022-12-01&rft.volume=4&rft.issue=12&rft.spage=100595&rft.epage=100595&rft.pages=100595-100595&rft.artnum=100595&rft.issn=2589-5559&rft.eissn=2589-5559&rft_id=info:doi/10.1016/j.jhepr.2022.100595&rft_dat=%3Cproquest_doaj_%3E2742656391%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c627t-dccebfdae4fd1e4e1e84b86716a151373baf27de05b70515fa7e2347f2a91de93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2742656391&rft_id=info:pmid/&rfr_iscdi=true